For decades, the clinical management of uveitis has been guided by the “art” of the slit-lamp exam and the subjective interpretation of inflammatory signs. While the Standardization of Uveitis Nomenclature (SUN) working group provided a vital framework in 2005, its reliance on ordinal grading for anterior chamber (AC) cells and vitreous haze remains limited by moderate reproducibility and a lack of sensitivity to subtle clinical changes.
As retina specialists, we are accustomed to the precision of quantitative metrics in managing diabetic retinopathy and AMD. The field of uveitis is now undergoing a similar transformation. Advances in Optical Coherence Tomography (OCT), OCT Angiography (OCTA), and Artificial Intelligence (AI) are shifting the paradigm from qualitative grading to objective, repeatable digital biomarkers. This post explores the current state of quantitative imaging and how these tools are redefining how we assess uveitis activity.
1. The Anterior Segment: Beyond the Slit-Lamp
The traditional 1×1 mm slit beam remains the gold standard for AC cell grading, yet it is a “single moment estimate” that can miss within-grade fluctuations.
- Automated Cell Counting: Modern Anterior Segment OCT (AS-OCT) systems offer axial resolutions of ~5 µm, allowing for the detection of individual leukocytes (5–7 µm in diameter). Studies show that AS-OCT-derived cell counts correlate strongly (0.94–0.97) with SUN grades and provide a reproducible longitudinal track of disease course.
- The ARI Index for Flare: Quantifying flare has historically required laser flare photometry (LFP), which is precise but lacks widespread clinical availability. AS-OCT offers a non-invasive alternative through the Aqueous-to-Air Relative Intensity (ARI) index. By normalizing AC brightness to a reference air signal, clinicians can objectively measure flare, which increases significantly during active inflammation.
2. Vitreous Inflammation: From Haze to Ratios
Vitreous haze assessment is notoriously difficult at lower grades. While photographic scales like the NIH 6-step or Miami 9-step have improved standardization, they remain ordinal.
- OCT Vitreous Intensity (OCT VI): To overcome the “haze” of subjectivity, researchers introduced the Vit:RPE relative intensity ratio, which normalizes vitreous signal to the stable RPE. Because RPE pathology can confound this, the OCT VI index—a log-transformed ratio of vitreous signal to total B-scan signal—has emerged as a robust marker that correlates better with visual acuity than traditional slit-lamp grading.
- Vitreous Cell Density: While cells were once considered too diffuse to count, automated OCT analysis can now quantify hyperreflective dots in the vitreous, providing a metric that tracks closely with disease resolution.
3. Retinal Biomarkers: Ultrastructure and Vasculature
Macular involvement is the leading cause of vision loss in uveitis. While Central Subfield Thickness (CST) is our standard metric, it often lags behind inflammatory resolution.
- Vessel Caliber Dynamics: Emerging data suggests that Central Retinal Vein Equivalent (CRVE) and Central Retinal Artery Equivalent (CRAE) are novel biomarkers of activity. Retinal vessels significantly dilate during active inflammation and constrict upon quiescence, independent of the uveitis subtype.
- Ultrastructural Integrity: Beyond thickness, we must look at the Ellipsoid Zone (EZ) and Disorganization of the Retinal Inner Layers (DRIL). Quantitative mapping of EZ surface area loss has been shown to correlate directly with symptomatic improvement and visual gains in conditions like APMPPE.
- Quantitative Fluorescein Angiography (FFA): The transition from semiquantitative ASUWOG scores to automated leakage area measurements is underway. AI models can now segment vascular leakage with accuracy comparable to experts, though challenges like threshold dependence and image phase selection remain.
4. The Choroid: CVI and Choriocapillaris Flow
In stromal choroiditis (e.g., VKH, Birdshot), structural OCT and OCTA are becoming indispensable.
- Choroidal Vascularity Index (CVI): Unlike choroidal thickness, which is influenced by age and diurnal rhythm, CVI—the ratio of luminal to total choroidal area—aims to capture the vascular-stromal balance. While some studies show CVI increases during active VKH due to vessel congestion, results across different uveitis entities remain heterogeneous, requiring careful interpretation of binarization methods.
- Flow Deficits (FD): In choriocapillaritis (e.g., serpiginous choroiditis), OCTA can quantify Flow Deficits, which appear as hyporeflective areas of reduced perfusion. These metrics allow for precise longitudinal tracking of lesion progression or recovery.
5. The Optic Nerve: A Rapid Surrogate
Optic disc edema is a common, yet sometimes subtle, sign of active posterior inflammation.
- Peripapillary OCT (pRNFL): Thickening of the pRNFL serves as a non-invasive surrogate for disc leakage. It has been shown to increase during active phases and decline with treatment in nearly all uveitis subtypes, including pediatric cases. However, clinicians must distinguish between transient inflammatory swelling and permanent axonal loss in chronic disease.
- Peripapillary OCTA: Peripapillary vessel density often appears reduced in active uveitis. This “paradoxical” reduction is likely due to microvascular dysfunction, RNFL swelling-induced compression, or shadowing artifacts from the thickened nerve fiber layer.
6. The Future: AI and Composite Scores
The biological heterogeneity of uveitis makes single-metric assessment difficult. The future lies in Composite Activity Scores.
- SS-UAS: The Swept-Source OCT-derived Uveitis Activity Score integrates AC dots, vitreous intensity, and retinal thickening into a single continuous score.
- End-to-End AI: Deep learning frameworks are being developed to process raw images and generate activity grades without manual input. While these “black box” models are powerful, their lack of transparency remains a barrier to clinical adoption.
Clinical Pearls for the Retina Specialist
- Standardize Your Protocols: Quantitative metrics are highly sensitive to device settings, brightness normalization, and slab definitions.
- Look Beyond CST: Incorporate EZ integrity and peripapillary RNFL thickness into your longitudinal monitoring for a more comprehensive view of activity.
- Acknowledge Reversibility Limits: Retinal vessel density on OCTA may reflect permanent microvascular damage rather than reversible inflammation, limiting its utility as a standalone “activity” marker.
Conclusion
Quantitative imaging is moving uveitis care away from subjective “plus/minus” grading toward a future of precision digital biomarkers. While we await large-scale validation and cross-platform calibration, these tools already offer the ability to detect relapses earlier and differentiate structural damage from active inflammation with greater fidelity than ever before.
Reference
Nabavi A, Zarei M, Shome A, Rupenthal ID, Caspi RR, Davis J, Yousefi S. Quantitative imaging for assessing uveitis activity: A comprehensive review. Survey of Ophthalmology. 2026. https://doi.org/10.1016/j.survophthal.2026.04.003.
